Paroxysmal Nocturnal Hemoglobinuria

conference reporter

by Jaroslaw P. Maciejewski, MD, PhD, FACP

As seen at the 64th ASH Annual Meeting and Exposition, promising data on proximal complement inhibition suggest that changes are in store for parox......READ MORE

conference reporter

by Jaroslaw P. Maciejewski, MD, PhD, FACP

Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by substantial clinical heterogeneity that may be influenced by the clonal characteristi......READ MORE

conference reporter

by Carlos M. de Castro III, MD

Data from several studies presented at the 64th ASH Annual Meeting and Exposition highlight the promise of proximal complement inhibition in the tr......READ MORE

conference reporter

by Carlos M. de Castro III, MD

Researchers at the 64th ASH Annual Meeting and Exposition presented data from several studies evaluating the treatment of paroxysmal nocturnal hemo......READ MORE

conference reporter

by Ronald S. Go, MD

Complications such as thrombosis in patients with paroxysmal nocturnal hemoglobinuria (PNH) are less common in the era of complement protein C5 inh......READ MORE